XML 22 R4.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Research and development expenses, net $ 10,210 $ 8,638 $ 4,089
Marketing and sales expenses 1,350 987 1,015
General and administrative expenses 3,469 3,696 3,753
Operating loss 15,029 13,321 8,857
Equity in net loss (gain) of an affiliated company 839 2,905 (156)
Financial expenses (income), net (429) (1,569) 7,241
Net Loss $ 15,439 $ 14,657 $ 15,942
Basic and diluted loss per share (in USD) (in Dollars per share) $ (0.10) $ (0.12) $ (0.17)
Weighted average number of shares outstanding used in computing basic and diluted loss per share - in thousands (in Shares) 149,534 120,612 94,401